you are here: Home News Pharma Industry

Pharma Industry

Eli Lilly to invest over $1 billion in India to expand manufacturing capacity
India bulk drug makers start preparing for Ozempic patent expiry
Pharma products face stricter scrutiny over drug brand name confusion: Report
Budget wish list: Pharma industry seeks tax benefits, effective intellectual property rights regime
Entero IPO: Should investors pop the flotation pill?
Cipla: Sailing well on the US pharma business front
Hetero to invest Rs 1,000 crore in AP over two years to expand pharma business
Pharma sector gets first tranche of payment under under PLI scheme
India’s pharma industry’s problems need to be fixed, now!
Research crucial for Indian pharma industry to move from ‘volume’ to ‘value’: Mansukh Mandaviya
Govt wants to ease compliance burden on pharma industry: Mansukh Mandaviya
Indian pharma industry estimated to grow 9-11% in 2021-22: ICRA
Mansukh Mandaviya urges pharma industry to make India a manufacturing hub
Veterans Unpacked | D.S. Brar: "Your network is your net worth, and your credibility is your currency"
Gland Pharma’s focus on injectables yields superior growth
I am sure global pharma industry will support India's WTO proposal of IP waiver for COVID-19: Piyush Goyal
Indian pharma firms go local seeking to end reliance on China
Budget 2021 could be the vaccine for the pharmaceutical industry
Coronavirus pandemic | Centre to expedite clearances to bulk drug projects to fight COVID-19
3-Point Analysis | API export restriction: Takeaways for pharma industry
Indian pharma industry likely to grow at 10-13% in FY'21: ICRA
Editor's Take | Budget 2020: The pharma industry's wishlist
NPPA issues notices to Lupin, Ranbaxy, others for selling FDCs without price approval
Pharma: Here's what all happened in the sector last week
Budget 2017: Weighted deductions for incurring pharma R&D should continue

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Pharma Industry

Eli Lilly to invest over $1 billion in India to expand manufacturing capacity

India bulk drug makers start preparing for Ozempic patent expiry

Pharma products face stricter scrutiny over drug brand name confusion: Report

Budget wish list: Pharma industry seeks tax benefits, effective intellectual property rights regime

Entero IPO: Should investors pop the flotation pill?

Cipla: Sailing well on the US pharma business front

Hetero to invest Rs 1,000 crore in AP over two years to expand pharma business

Pharma sector gets first tranche of payment under under PLI scheme

India’s pharma industry’s problems need to be fixed, now!

Research crucial for Indian pharma industry to move from ‘volume’ to ‘value’: Mansukh Mandaviya

Govt wants to ease compliance burden on pharma industry: Mansukh Mandaviya

Indian pharma industry estimated to grow 9-11% in 2021-22: ICRA

Mansukh Mandaviya urges pharma industry to make India a manufacturing hub

Veterans Unpacked | D.S. Brar: "Your network is your net worth, and your credibility is your currency"

Gland Pharma’s focus on injectables yields superior growth

I am sure global pharma industry will support India's WTO proposal of IP waiver for COVID-19: Piyush Goyal

Indian pharma firms go local seeking to end reliance on China

Budget 2021 could be the vaccine for the pharmaceutical industry

Coronavirus pandemic | Centre to expedite clearances to bulk drug projects to fight COVID-19

3-Point Analysis | API export restriction: Takeaways for pharma industry

Indian pharma industry likely to grow at 10-13% in FY'21: ICRA

Editor's Take | Budget 2020: The pharma industry's wishlist

NPPA issues notices to Lupin, Ranbaxy, others for selling FDCs without price approval

Pharma: Here's what all happened in the sector last week

Budget 2017: Weighted deductions for incurring pharma R&D should continue